Exane Derivatives’s Workhorse Group WKHS Stock Holding History

Exane Derivatives’s Portfolio WKHS Stock Details WKHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2	Closed	-$32.5K	–	1014
2022 Q1	$32.5K	Buy	+2	New	+$22K	0.01%	617
2021 Q4	–	Sell	-3	Closed	-$60.9K	–	1063
2021 Q3	$60.9K	Hold	3	–	–	0.01%	600
2021 Q2	$98.1K	Hold	3	–	–	0.02%	537
2021 Q1	$108K	Sell	3 -1	-25%	-$71.8K	0.03%	414
2020 Q4	$239K	Buy	+4	New	+$260K	0.07%	284

Other funds holding WKHS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Exane Derivatives's WKHS Position: Q2 2022 in Review

Exane Derivatives sold out of Workhorse Group (WKHS) in Q2 2022, closing a stake of 2 shares — an estimated $32.5K sold.

Exane Derivatives first reported a position in WKHS in Q4 2020 and held it in 5 quarters. The position peaked at $239K in Q4 2020. 144 funds tracked by Wall St. Rank hold WKHS as of Q2 2022.

Exane Derivatives reported no remaining Workhorse Group position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 2 Workhorse Group shares in Q2 2022, an estimated $32.5K.
Exane Derivatives first reported a position in Workhorse Group in Q4 2020 and held it in 5 quarters.
Exane Derivatives's Workhorse Group position peaked at $239K in Q4 2020.
144 funds tracked by Wall St. Rank held Workhorse Group as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.